✦ LIBER ✦

Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis

✍ Scribed by Murat Akyildiz; Zeki Karasu; Murat Zeytunlu; Unal Aydin; Tijen Ozacar; Murat Kilic

Book ID: 108951083
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 74 KB
Volume: 22
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2006.04609.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evolution of hepatitis B virus sequence

Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy

✍ Kyun-Hwan Kim; Kwang-Hee Lee; Hye-Young Chang; Sang Hoon Ahn; Shuping Tong; Youn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

## Abstract Recurrent hepatitis B virus (HBV) infection after liver transplantation can be prevented by prophylactic hepatitis B immune globulin (HBIG) and lamivudine therapy. However, reinfection may still occur due to the emergence of immune escape mutants and mutants of the YMDD motif. The full

Occult hepatitis B virus infection of do

Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis

✍ Cindy Ka Yee Cheung; Chung Mau Lo; Kwan Man; George Ka Kit Lau 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB 👁 1 views

Liver grafts from donors positive for antibody to hepatitis B core antigen (anti-HBc) may be used for transplantation in patients with hepatitis B virus (HBV)-related liver disease, and an occult HBV infection may develop from either source. Liver biopsy was performed for 31 patients who remained se

Prophylaxis of hepatitis B virus recurre

Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants

✍ Alfredo Marzano; Pietro Lampertico; Vincenzo Mazzaferro; Silvia Carenzi; Mauro V 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Hepatitis B immunoglobulin discontinuati

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation

✍ Alberto Sánchez-Fueyo; Antoni Rimola; Luis Grande; Josep Costa; Antoni Mas; Migu 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

A randomized study of adefovir dipivoxil

A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post–liver transplantation hepatitis B prophylaxis

✍ Peter W. Angus; Scott J. Patterson; Simone I. Strasser; Geoffrey W. McCaughan; E 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

Clinical course and predictive factors o

Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients

✍ Mashu Aizawa; Akihito Tsubota; Kiyotaka Fujise; Keiko Tatsuzawa; Midori Kono; Sa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract The aims of this study were to assess the long‐term efficacy of lamivudine (LAM) plus adefovir dipivoxil (ADV) combination therapy in patients with chronic hepatitis B resistant to LAM, to identify predictive factors of complete viral response (HBV‐DNA <2.6 log copies/ml at 12 months of